Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report

BACKROUND: We describe one of the first cases of a Posterior reversible encephalopathy syndrome (PRES) under tocilizumab as treatment of Giant cell arteritis (GCA). CASE PRESENTATION: A 65-year-old female with known GCA and treatment with Tocilizumab (TCZ) developed a convulsive epileptic seizure fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Butryn, Michaela, Mewes, Sabine, Feist, Eugen, Beuing, Oliver, Müller, Christian, Neumann, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218423/
https://www.ncbi.nlm.nih.gov/pubmed/34157987
http://dx.doi.org/10.1186/s12883-021-02231-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218423/
https://www.ncbi.nlm.nih.gov/pubmed/34157987
http://dx.doi.org/10.1186/s12883-021-02231-7

Ejemplares similares